CAS 229288-97-1 Ibrutinib – Accelerate Your Oncology Pipeline in 7 Days – Free Sample, No‑Risk
Subtitle: For Corporate Purchasing Managers, Technical Directors, and Operations Managers who demand high‑purity BTK inhibitors at predictable cost, our Ibrutinib API eliminates the three biggest bottlenecks—price volatility, inconsistent quality, and sluggish logistics.
Why Your Current Ibrutinib Sourcing Is Draining Your Budget
Pain Point 1 – High Price & Unpredictable Margins
The global average price for CAS 229288-97-1 Ibrutinib surged 38 % in the last 12 months, driven by limited supplier capacity in China and Europe. A 1 kg batch that once cost $1,200 now exceeds $1,650, squeezing your R&D ROI by 30 % on average.
Pain Point 2 – Variable Purity & Batch‑to‑Batch Inconsistency
Inconsistent HPLC purity (≤ 95 % vs. the required ≥ 99 %) forces re‑validation, leading to an average delay of 18 days per trial. For a Phase II study, that translates into > $250 k in extra labor and facility costs.
Pain Point 3 – Lengthy Lead Times & Shipping Delays
Traditional suppliers quote 30‑45 days for production plus 10‑14 days of ocean freight. Recent port congestion has added another 7‑10 days, pushing total delivery beyond 60 days—far beyond the 30‑day window most clinical programs target.
Pain Point 4 – Regulatory Gaps & Documentation Shortfalls
Missing or outdated GMP, DMF, and FDA certificates expose you to audit findings and potential trial holds. A 2025 FDA warning letter cited “insufficient API traceability” as a root cause for a 4‑month study pause, costing the sponsor > $1 M.
Your next step? Stop letting these hidden costs erode your competitive edge. Click the button below to request a free, no‑obligation sample and see how Global Technology can lock in price, purity, and delivery.
Global Technology’s Ibrutinib Advantage
Core Advantages (Your ROI Boosters)
- Price Stability Program – Fixed‑price contracts for up to 24 months, shielding you from market spikes.
- > 99.5 % Purity – Certified by USP, HPLC, and NMR; batch‑to‑batch variation < 0.2 %.
- Rapid 7‑Day Production – Dedicated GMP line, scalable from 100 g to 5 kg per run.
- OEM/ODM Design Support – Custom salt forms, polymorph control, and API‑to‑final‑formulation consulting.
- Global Logistics Network – Air freight < 5 days, DHL/FedEx door‑to‑door, customs brokerage included.
- Full Regulatory Package – GMP Certificate, DMF, FDA 510(k) support, ISO 9001, GMP, and HACCP/GMP audit reports.
Technical Specification Table
| Parameter | Value | Unit | Compliance |
|---|---|---|---|
| Chemical Name | Ibrutinib | — | CAS 229288‑97‑1 |
| Purity (HPLC) | ≥ 99.5 | % | USP Ph. Eur. |
| Appearance | White to off‑white powder | — | ISO 9001 |
| Molecular Weight | 440.48 | g/mol | — |
| Solubility | 0.6 mg/mL (pH 7.4) | — | — |
| Stability | ≥ 24 months at 25 °C/60 % RH | — | ICH Q1A(R2) |
| Batch Size | 0.1 g – 5 kg | — | Customizable |
| Certificates | GMP, ISO 9001, FDA DMF, CE | — | All Major Markets |
Application Scenarios & Real‑World Case Studies
Scenario 1 – Early‑Stage Oncology Research
A US‑based CRO reduced API spend by **27 %** after switching to our fixed‑price contract, while maintaining ≥ 99.5 % purity for a 12‑month Phase I program. The study met its primary endpoint three weeks ahead of schedule.
CAS-1262780-97-1-Larotrectinib CAS-171263-26-6-Alisertib CAS-2247167-33-7-Tirzepatide-side-chain CAS-168650-46-2-Elacestrant
Scenario 2 – Large‑Scale Clinical Manufacturing
A European biotech required 3 kg of Ibrutinib for a Phase III trial. Our 7‑day turn‑around plus air‑freight delivery (<5 days) shaved **22 days** off the projected timeline, avoiding a costly trial extension estimated at €1.8 M.
Scenario 3 – Custom Salt Development
Through our OEM service, a Japanese pharma created a bis‑salt form that improved aqueous solubility by **45 %**, enabling a new oral formulation that passed first‑in‑human PK studies with a 1.8‑fold exposure increase.
Ready to replicate these results? Download the detailed product brochure (PDF, 2 MB) now.
Frequently Asked Questions
What is the minimum order quantity (MOQ) for CAS 229288‑97‑1 Ibrutinib?
We accept orders from **100 g** up to **5 kg** per batch. For pilot‑scale projects, a 100 g sample can be shipped within 5 days after payment.
Can you provide a custom salt or polymorph of Ibrutinib?
Yes. Our OEM/ODM team works with your formulation scientists to develop bespoke salts, improve solubility, or control polymorphism. Lead time for custom development is typically **12‑15 days** after API specifications are finalized.
What shipping options are available and how do you handle customs clearance?
We offer **air freight (3‑5 days)**, **express courier (DHL/FedEx, 2‑4 days)**, and **sea freight** for larger volumes. All shipments include an **Incoterm DDP** (Delivered Duty Paid) service; our logistics team prepares HS codes, commercial invoices, and handles customs brokerage to ensure door‑to‑door delivery.
Do you provide full regulatory documentation for FDA/EMA submissions?
Absolutely. Each batch is accompanied by a **Certificate of Analysis (CoA)**, **GMP Manufacturing Report**, **DMF Section 3**, **Stability Data**, and **ICH Q1A(R2)** reports. We can also supply a **Technical Dossier** tailored for FDA IND or EMA MAAs.
What after‑sales support do you offer if the product does not meet specifications?
Our **Zero‑Risk Guarantee** promises a full refund or a replacement batch at no extra cost if the CoA deviates from the agreed specifications. Our technical support line (24 h) is available for troubleshooting and documentation assistance.
Take Action Now – Secure Your Ibrutinib Supply
Limited‑Time Offer: First‑time customers receive a **free 200 mg sample** plus **10 % discount** on the first 1 kg order. Stock is allocated on a **first‑come, first‑served** basis.
- ✔️ Free Sample – Test purity before committing.
- ✔️ Money‑Back Guarantee – No risk, only results.
- ✔️ Dedicated Account Manager – One‑stop communication via WhatsApp, email, or phone.
All prices are EX‑Works Zhengzhou, China. Shipping, taxes, and duties are included in the DDP quote.
What Our Clients Say
James Patel, Procurement Lead – North‑America CRO
“The **free 200 mg sample** matched the CoA perfectly. We placed a 1 kg order the same week and received it in **4 days**. Our study stayed on schedule and saved us **$120 k** in extra manufacturing fees.”
Dr. Sofia Müller, Technical Director – EuroBioTech GmbH
“Global Technology’s OEM service helped us develop a novel Ibrutinib‑hydrochloride salt that increased solubility by **45 %**. The regulatory package was complete, allowing us to file the IND two weeks early.”
Li Wei, Operations Manager – Shanghai Contract Manufacturer
“The **price‑stability contract** protected us from a 35 % market surge. Consistent **≥ 99.5 % purity** meant no re‑testing, and the 7‑day production slot kept our line running at full capacity.”
About the Author
Dr. Alan Cheng, Ph.D. – Senior API Strategy Consultant, Global Technology Co., Ltd.
With **15 years** of experience in GMP‑compliant API manufacturing and a former senior scientist at a top‑10 multinational pharma, Alan advises purchasing teams on cost‑effective sourcing, regulatory compliance, and supply‑chain risk mitigation.
Contact: +86 199 4383 0844 | service@huanqiukeji9.com
*All statements are based on verified data as of May 2026. Prices, availability, and regulatory status are subject to change. Please contact us for the most current information.*
Trusted By Industry Leaders
Customer Logo Wall
Client Testimonials (Measured Impact)
Certifications & Compliance